|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Smyth EC, Nilsson M, Grabsch HI, van
Grieken NC and Lordick F: Gastric cancer. Lancet. 396:635–648.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hochwald SN, Kim S, Klimstra DS, Brennan
MF and Karpeh MS: Analysis of 154 actual five-year survivors of
gastric cancer. J Gastrointest Surg. 4:520–525. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Karimi P, Islami F, Anandasabapathy S,
Freedman ND and Kamangar F: Gastric cancer: Descriptive
epidemiology, risk factors, screening, and prevention. Cancer
Epidemiol Biomarkers Prev. 23:700–713. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Young E, Philpott H and Singh R:
Endoscopic diagnosis and treatment of gastric dysplasia and early
cancer: Current evidence and what the future may hold. World J
Gastroenterol. 27:5126–5151. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mabe K, Inoue K, Kamada T, Kato K, Kato M
and Haruma K: Endoscopic screening for gastric cancer in Japan:
Current status and future perspectives. Dig Endosc. 34:412–419.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen C, Chen Q, Zhao Q, Liu M and Guo J:
Value of combined detection of serum CEA, CA72-4, CA19-9, CA15-3
and CA12-5 in the diagnosis of gastric cancer. Ann Clin Lab Sci.
47:260–263. 2017.PubMed/NCBI
|
|
8
|
Jelski W and Mroczko B: Molecular and
circulating biomarkers of gastric cancer. Int J Mol Sci.
23:75882022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kalluri R and LeBleu VS: The biology,
function, and biomedical applications of exosomes. Science.
367:eaau69772020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu R, Rai A, Chen M, Suwakulsiri W,
Greening DW and Simpson RJ: Extracellular vesicles in
cancer-implications for future improvements in cancer care. Nat Rev
Clin Oncol. 15:617–638. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kinoshita T, Yip KW, Spence T and Liu FF:
MicroRNAs in extracellular vesicles: potential cancer biomarkers. J
Hum Genet. 62:67–74. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qian Z, Shen Q, Yang X, Qiu Y and Zhang W:
The role of extracellular vesicles: An epigenetic view of the
cancer microenvironment. Biomed Res Int. 2015:6491612015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu YX, Pu SD, Li X, Yu ZW, Zhang YT, Tong
XW, Shan YY and Gao XY: Exosomal ncRNAs: Novel therapeutic target
and biomarker for diabetic complications. Pharmacol Res.
178:1061352022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liberati A, Altman DG, Tetzlaff J, Mulrow
C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J
and Moher D: The PRISMA statement for reporting systematic reviews
and meta-analyses of studies that evaluate health care
interventions: Explanation and elaboration. PLoS Med.
6:e10001002009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Whiting PF, Rutjes AW, Westwood ME,
Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA and Bossuyt
PM; QUADAS-2 Group, : QUADAS-2: A revised tool for the quality
assessment of diagnostic accuracy studies. Ann Intern Med.
155:529–536. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Egger M, Davey Smith G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zamora J, Abraira V, Muriel A, Khan KS and
Coomarasamy A: Meta-DiSc: A software for meta-analysis of test
accuracy data. BMC Med Res Methodol. 6:312006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dias S, Welton NJ, Sutton AJ and Ades AE:
NICE DSU technical support document 2: A generalised linear
modelling framework for pairwise and network meta-analysis of
randomised controlled trials [Internet]. NICE Decision Support Unit
Technical Support Documents London: National Institute for Health
and Care Excellence (NICE); 2014
|
|
19
|
Zhou H, Shen W, Zou H, Lv Q and Shao P:
Circulating exosomal long non-coding RNA H19 as a potential novel
diagnostic and prognostic biomarker for gastric cancer. J Int Med
Res. 48:3000605209342972020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zheng P, Zhang H, Gao H, Sun J, Li J,
Zhang X, Gao L, Ma P and Li S: Plasma exosomal long noncoding RNA
lnc-SLC2A12-10:1 as a novel diagnostic biomarker for gastric
cancer. Onco Targets Ther. 13:4009–4018. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zheng P, Gao H, Xie X and Lu P: Plasma
exosomal hsa_circ_0015286 as a potential diagnostic and prognostic
biomarker for gastric cancer. Pathol Oncol Res. 28:16104462022.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng GD, Xu ZY, Hu C, Lv H, Xie HX, Huang
T, Zhang YQ, Chen GP, Fu YF and Cheng XD: Exosomal miR-590-5p in
serum as a biomarker for the diagnosis and prognosis of gastric
cancer. Front Mol Biosci. 8:6365662021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao R and Zhang Y, Zhang X, Yang Y, Zheng
X, Li X, Liu Y and Zhang Y: Exosomal long noncoding RNA HOTTIP as
potential novel diagnostic and prognostic biomarker test for
gastric cancer. Mol Cancer. 17:682018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Y, Huang F, Xu N, Wang J, Li D and
Yin L: Overexpression of serum extracellular vesicle
microRNA-215-5p is associated with early tumor recurrence and poor
prognosis of gastric cancer. Clinics (Sao Paulo). 76:e20812021.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang J, Li X, Wei S, Peng L, Sang H, Jin
D, Chen M, Dang Y and Zhang G: Evaluation of the diagnostic
potential of a plasma exosomal miRNAs panel for gastric cancer.
Front Oncol. 11:6834652021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu H, Zhou J, Tang J, Min X, Yi T, Zhao J
and Ren Y: Identification of serum exosomal lncRNA MIAT as a novel
diagnostic and prognostic biomarker for gastric cancer. J Clin Lab
Anal. 34:e233232020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xiao K, Li S, Ding J, Wang Z, Wang D, Cao
X, Zhang Y and Dong Z: Expression and clinical value of circRNAs in
serum extracellular vesicles for gastric cancer. Front Oncol.
12:9628312022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wei S, Peng L, Yang J, Sang H, Jin D, Li
X, Chen M, Zhang W, Dang Y and Zhang G: Exosomal transfer of
miR-15b-3p enhances tumorigenesis and malignant transformation
through the DYNLT1/Caspase-3/Caspase-9 signaling pathway in gastric
cancer. J Exp Clin Cancer Res. 39:322020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang N, Wang L, Yang Y, Gong L, Xiao B and
Liu X: A serum exosomal microRNA panel as a potential biomarker
test for gastric cancer. Biochem Biophys Res Commun. 493:1322–1328.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang JF, Jiang YM, Zhan WH, Ye SP, Li TY
and Zhang JN: Screening of serum exosomal miRNAs as diagnostic
biomarkers for gastric cancer using small RNA sequencing. J Oncol.
2022:53465632022.PubMed/NCBI
|
|
31
|
Tang S, Cheng J, Yao Y, Lou C, Wang L,
Huang X and Zhang Y: Combination of four serum exosomal MiRNAs as
novel diagnostic biomarkers for early-stage gastric cancer. Front
Genet. 11:2372022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tang G, Wang J, Dong W, Dai K and Du J:
Exosomal miRNA expression profiling and the roles of exosomal
miR-4741, miR-32, miR-3149, and miR-6727 on gastric cancer
progression. Biomed Res Int. 2022:12638122022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shi Y, Wang Z, Zhu X, Chen L, Ma Y, Wang
J, Yang X and Liu Z: Exosomal miR-1246 in serum as a potential
biomarker for early diagnosis of gastric cancer. Int J Clin Oncol.
25:89–99. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shao Y, Tao X, Lu R, Zhang H, Ge J, Xiao
B, Ye G and Guo J: Hsa_circ_0065149 is an indicator for early
gastric cancer screening and prognosis prediction. Pathol Oncol
Res. 26:1475–1482. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Piao HY, Guo S, Wang Y and Zhang J:
Exosomal long non-coding RNA CEBPA-AS1 inhibits tumor apoptosis and
functions as a non-invasive biomarker for diagnosis of gastric
cancer. Onco Targets Ther. 13:1365–1374. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Okuda Y, Shimura T, Iwasaki H, Katano T,
Kitagawa M, Nishigaki R, Fukusada S, Natsume M, Tanaka M, Nishie H,
et al: Serum exosomal dicer is a useful biomarker for early
detection of differentiated gastric adenocarcinoma. Digestion.
102:640–649. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lu X, Lu J, Wang S, Zhang Y, Ding Y, Shen
X, Jing R, Ju S, Chen H and Cong H: Circulating serum exosomal
miR-92a-3p as a novel biomarker for early diagnosis of gastric
cancer. Future Oncol. 17:907–919. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lin LY, Yang L, Zeng Q, Wang L, Chen ML,
Zhao ZH, Ye GD, Luo QC, Lv PY, Guo QW, et al: Tumor-originated
exosomal lncUEGC1 as a circulating biomarker for early-stage
gastric cancer. Mol Cancer. 17:842018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li S, Zhang M, Zhang H, Hu K, Cai C, Wang
J, Shi L, Ma P, Xu Y and Zheng P: Exosomal long noncoding RNA
lnc-GNAQ-6:1 may serve as a diagnostic marker for gastric cancer.
Clin Chim Acta. 501:252–257. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kahroba H, Samadi N, Mostafazadeh M,
Hejazi MS, Sadeghi MR, Hashemzadeh S, Eftekhar Sadat AT and Karimi
A: Evaluating the presence of deregulated tumoral onco-microRNAs in
serum-derived exosomes of gastric cancer patients as noninvasive
diagnostic biomarkers. Bioimpacts. 12:127–138. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Guo X, Lv X, Ru Y, Zhou F, Wang N, Xi H,
Zhang K, Li J, Chang R, Xie T, et al: Circulating exosomal gastric
cancer-associated long noncoding RNA1 as a biomarker for early
detection and monitoring progression of gastric cancer: A
multiphase study. JAMA Surg. 155:572–579. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ge L, Zhang N, Li D, Wu Y, Wang H and Wang
J: Circulating exosomal small RNAs are promising non-invasive
diagnostic biomarkers for gastric cancer. J Cell Mol Med.
24:14502–14513. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Dong Z, Sun X, Xu J, Han X, Xing Z, Wang
D, Ge J, Meng L and Xu X: Serum membrane type 1-matrix
metalloproteinase (MT1-MMP) mRNA protected by exosomes as a
potential biomarker for gastric cancer. Med Sci Monit.
25:7770–7783. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chung KY, Quek JM, Neo SH and Too HP:
Polymer-based precipitation of extracellular vesicular miRNAs from
serum improve gastric cancer miRNA biomarker performance. J Mol
Diagn. 22:610–618. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cai C, Zhang H, Zhu Y, Zheng P, Xu Y, Sun
J, Zhang M, Lan T, Gu B, Li S and Ma P: Serum exosomal long
noncoding RNA pcsk2-2:1 as a potential novel diagnostic biomarker
for gastric cancer. Onco Targets Ther. 12:10035–10041. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Helwa I, Cai J, Drewry MD, Zimmerman A,
Dinkins MB, Khaled ML, Seremwe M, Dismuke WM, Bieberich E, Stamer
WD, et al: A Comparative study of serum exosome isolation using
differential ultracentrifugation and three commercial reagents.
PLoS One. 12:e01706282017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hu Y, Fang JY and Xiao SD: Can the
incidence of gastric cancer be reduced in the new century? J Dig
Dis. 14:11–15. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang J, Yu JC, Kang WM and Ma ZQ:
Treatment strategy for early gastric cancer. Surg Oncol.
21:119–123. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Tang XH, Guo T, Gao XY, Wu XL, Xing XF, Ji
JF and Li ZY: Exosome-derived noncoding RNAs in gastric cancer:
Functions and clinical applications. Mol Cancer. 20:992021.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang J, Li S, Li L, Li M, Guo C, Yao J
and Mi S: Exosome and exosomal microRNA: Trafficking, sorting, and
function. Genomics Proteomics Bioinformatics. 13:17–24. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhu L, Li J, Gong Y, Wu Q, Tan S, Sun D,
Xu X, Zuo Y, Zhao Y, Wei YQ, et al: Exosomal tRNA-derived small RNA
as a promising biomarker for cancer diagnosis. Mol Cancer.
18:742019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Li C, Ni YQ, Xu H, Xiang QY, Zhao Y, Zhan
JK, He JY, Li S and Liu YS: Roles and mechanisms of exosomal
non-coding RNAs in human health and diseases. Signal Transduct
Target Ther. 6:3832021. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Anastasiadou E, Jacob LS and Slack FJ:
Non-coding RNA networks in cancer. Nat Rev Cancer. 18:5–18. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Saaoud F, Drummer IVC, Shao Y, Sun Y, Lu
Y, Xu K, Ni D, Jiang X, Wang H and Yang X: Circular RNAs are a
novel type of non-coding RNAs in ROS regulation, cardiovascular
metabolic inflammations and cancers. Pharmacol Ther.
220:1077152021. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Long F, Lin Z, Li L, Ma M, Lu Z, Jing L,
Li X and Lin C: Comprehensive landscape and future perspectives of
circular RNAs in colorectal cancer. Mol Cancer. 20:262021.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhang Y, Liang W, Zhang P, Chen J, Qian H,
Zhang X and Xu W: Circular RNAs: Emerging cancer biomarkers and
targets. J Exp Clin Cancer Res. 36:1522017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Yu H, Guan Z, Cuk K, Brenner H and Zhang
Y: Circulating microRNA biomarkers for lung cancer detection in
Western populations. Cancer Med. 7:4849–4862. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Jia E, Ren N, Shi X, Zhang R, Yu H, Yu F,
Qin S and Xue J: Extracellular vesicle biomarkers for pancreatic
cancer diagnosis: A systematic review and meta-analysis. BMC
Cancer. 22:5732022. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Wei Y, Guo S, Tang J, Wen J, Wang H, Hu X
and Gu Q: MicroRNA-19b-3p suppresses gastric cancer development by
negatively regulating neuropilin-1. Cancer Cell Int. 20:1932020.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Chen Z, Liu K, Li L, Chen Y and Du S:
miR-215 promotes cell migration and invasion of gastric cancer by
targeting Retinoblastoma tumor suppressor gene 1. Pathol Res Pract.
213:889–894. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Li N, Zhang QY, Zou JL, Li ZW, Tian TT,
Dong B, Liu XJ, Ge S, Zhu Y, Gao J and Shen L: miR-215 promotes
malignant progression of gastric cancer by targeting RUNX1.
Oncotarget. 7:4817–4828. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Zang Y, Wang T, Pan J and Gao F: miR-215
promotes cell migration and invasion of gastric cancer cell lines
by targeting FOXO1. Neoplasma. 64:579–587. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Melo SA, Luecke LB, Kahlert C, Fernandez
AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari
N, et al: Glypican-1 identifies cancer exosomes and detects early
pancreatic cancer. Nature. 523:177–182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Vaidyanathan R, Soon RH, Zhang P, Jiang K
and Lim CT: Cancer diagnosis: From tumor to liquid biopsy and
beyond. Lab Chip. 19:11–34. 2018.PubMed/NCBI
|
|
65
|
Ye Q, Ling S, Zheng S and Xu X: Liquid
biopsy in hepatocellular carcinoma: Circulating tumor cells and
circulating tumor DNA. Mol Cancer. 18:1142019. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Cai X, Janku F, Zhan Q and Fan JB:
Accessing genetic information with liquid biopsies. Trends Genet.
31:564–575. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Yu W, Hurley J, Roberts D, Chakrabortty
SK, Enderle D, Noerholm M, Breakefield XO and Skog JK:
Exosome-based liquid biopsies in cancer: Opportunities and
challenges. Ann Oncol. 32:466–477. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Sidhom K, Obi PO and Saleem A: A review of
exosomal isolation methods: Is size exclusion chromatography the
best option? Int J Mol Sci. 21:64662020. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Livshits MA, Khomyakova E, Evtushenko EG,
Lazarev VN, Kulemin NA, Semina SE, Generozov EV and Govorun VM:
Corrigendum: Isolation of exosomes by differential centrifugation:
Theoretical analysis of a commonly used protocol. Sci Rep.
6:214472016. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Cvjetkovic A, Lötvall J and Lässer C: The
influence of rotor type and centrifugation time on the yield and
purity of extracellular vesicles. J Extracell Vesicles. 3:2014.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Yang XX, Sun C, Wang L and Guo XL: New
insight into isolation, identification techniques and medical
applications of exosomes. J Control Release. 308:119–129. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Böing AN, van der Pol E, Grootemaat AE,
Coumans FA, Sturk A and Nieuwland R: Single-step isolation of
extracellular vesicles by size-exclusion chromatography. J
Extracell Vesicles. 3:2014. View Article : Google Scholar
|
|
73
|
Cha BS, Park KS and Park JS: Signature
mRNA markers in extracellular vesicles for the accurate diagnosis
of colorectal cancer. J Biol Eng. 14:42020. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Fu F, Jiang W, Zhou L and Chen Z:
Circulating exosomal miR-17-5p and miR-92a-3p predict pathologic
stage and grade of colorectal cancer. Transl Oncol. 11:221–232.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Nazarova I, Slyusarenko M, Sidina E,
Nikiforova N, Semiglazov V, Semiglazova T, Aigner A, Rybakov E and
Malek A: Evaluation of colon-specific plasma nanovesicles as new
markers of colorectal cancer. Cancers (Basel). 13:39052021.
View Article : Google Scholar : PubMed/NCBI
|
